Overview
Yohta Shimada practices in Tokyo, Japan. Shimada is highly rated in 4 conditions, according to our data. Their top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Pompe Disease, GM1 Gangliosidosis, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 46 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Distinguished
- Mucopolysaccharidoses (MPS)Shimada isDistinguished. Learn about Mucopolysaccharidoses (MPS).
- Advanced
- GM1 GangliosidosisShimada isAdvanced. Learn about GM1 Gangliosidosis.
- Pompe DiseaseShimada isAdvanced. Learn about Pompe Disease.
- Experienced
- Bone Marrow TransplantShimada isExperienced. Learn about Bone Marrow Transplant.
- Fabry DiseaseShimada isExperienced. Learn about Fabry Disease.
- Farber LipogranulomatosisShimada isExperienced. Learn about Farber Lipogranulomatosis.
- GangliosidosisShimada isExperienced. Learn about Gangliosidosis.
- Pancreatic CancerShimada isExperienced. Learn about Pancreatic Cancer.
- Peripheral NeuropathyShimada isExperienced. Learn about Peripheral Neuropathy.